Top Markets
Coin of the day
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Ранг среди акций #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Цена акции
$22.26
Последняя синхронизация: 2024-03-22
Рыночная капитализация
$553.40M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Graphite Bio, Inc. (GRPH)

Категория

История дроблений акций Graphite Bio, Inc. (GRPH)
Акции Graphite Bio, Inc. (символ: GRPH) прошли через 0 дроблений.
Последнее дробление произошло Aug 31, 2026.
Одна акция GRPH, купленная до Aug 31, 2026, сейчас соответствует 0 акциям GRPH.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH